Companies

Eton Pharmaceuticals, Inc.

ETON · CIK 0001710340 · operating

$18.15+6.83%Last updated Mar 3, 1:26 AM

Key Statistics

Valuation

Market Cap$486.74M
P/E
Fwd P/E19.41
PEG
P/S6.92
P/B21.06
EV/EBITDA101.78
EV/Rev6.83

Profitability

Gross Margin60.01%
Op. Margin-6.66%
Net Margin-9.80%
ROE-15.65%
ROA-5.02%
FCF Margin2.42%

Financial Health

Current Ratio2.06
Debt/Equity2.12
Free Cash Flow$943,000
Div. Yield

Growth & Other

Revenue Growth23.29%
EPS Growth
Beta1.24
52W High$23
52W Low$11.09

About Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. (ETON) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $487 million, Eton Pharmaceuticals, Inc. is a small-cap company. The stock currently trades at $18.15, up 6.83% today, with a 52-week range of $11.09–$23.00. The company trades at a forward P/E of 19.4x.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-0.15-275.0%
2023$-0.04+88.9%
2022$-0.36
2021
2020
2019
2018

Annual Reports (10-K) · 7 filings

Report DateFiledAccession Number
2024-12-312025-03-180001437749-25-008136SEC ↗
2023-12-312024-03-140001437749-24-007853SEC ↗
2022-12-312023-03-160001493152-23-007933SEC ↗
2021-12-312022-03-160001493152-22-006990SEC ↗
2020-12-312021-03-160001493152-21-006122SEC ↗
2019-12-312020-03-050001493152-20-003451SEC ↗
2018-12-312019-03-250001493152-19-003817SEC ↗